Iron wire phlebitis – a disease of underestimated significance. COVID-19 as a factor increasing the risk of Mondor's disease
DOI:
https://doi.org/10.12775/JEHS.2023.47.01.001Keywords
iron wire phlebitis, COVID-19, Mondor's disease, superficial thrombophlebitis of the breast, thrombophlebitisAbstract
Mondor's Disease, also known as iron wire phlebitis, is a rare and self-limiting superficial
vein thrombophlebitis that presents with a palpable cord-like induration beneath the skin. Others
symptoms include: pain, swelling and redness of the affected area. It typically affects the vessels of
the chest wall, less frequently the vessels of the penis or the upper limbs. The etiology of the disease
is not fully understood, but it is known that it may be caused by local injuries or surgeries, and it
may accompany cancer or infections. The diagnosis is based in most cases on an anamnesis and
physical examination, confirmed by ultrasound. There are approximately 500 cases of this disease
described in the literature. Iron wire phlebitis is a disease of underappreciated importance, raising
awareness of this condition can facilitate the MD’ diagnosis and reduce unnecessary diagnostic
procedures.
A 36-year-old female patient detects a lump during breast self-examination. The lesion was
located in the upper outer quadrant of the right breast. The ultrasound revealed dilated venous
vessel with thrombosis, which led to diagnose Mondor's Disease. In this case the cause of increased
coagulation may be ablation or COVID-19 infection. It is necessary to find the etiological factors
predisposing to the disease, and extending the diagnosis to exclude other rheumatological,
hematological and neoplastic diseases. The patient received low-molecular-weight heparin, heparin
ointment, painkillers and anti-inflammatory drugs. After one week treatment, the change wasn’t
palpable. Then, instead of LMWH, oral sulodexide was used for treatment.
Thanks to awareness of this disease, it was possible to made an appropriate, quickly
diagnosis and implement treatment, as well as reduce unnecessary medical procedures. The early
diagnosis of MD can help to identify serious causes (for example breast cancer) at an early stage
which will allow to treatment previously undetected changes.
References
Obradovic K, Adzic N, Pavlovic Stankovic D, Petkovic I, Urban V, Milosevic Z.(2020)
Superficial Thrombophlebitis of the Breast (Mondor’s Disease): An Uncommon Localization of
Common Disease. Clinical Medicine Insights: Case Reports. 2020;13.
doi:10.1177/1179547620972414
Rountree KM., Barazi H., Aulick NF. (2023) Mondor Disease. In: StatPearls [Internet]. Treasure
Island (FL): StatPearls Publishing; https://www.ncbi.nlm.nih.gov/books/ NBK538282/
(retrieved: 10.07.2023)
Vijayan, P., Pang, F.T. (2023) Mondor’s disease of the breast in Asia: a forgotten diagnosis for
the front-line clinicians - a case report and literature review. Egyptian Journal of Radiology and
Nuclear Medicine. 54, 70. https://doi.org/10.1186/s43055-023-01020-1
Suganthan, N., Ratnasamy, V. Mondor’s disease – a rare cause of chest pain: a case report. J
Med Case Reports 12, 4 (2018). https://doi.org/10.1186/s13256-017-1530-x
Kibil W., Hodorowicz-Zaniewska D., Kulig J. (2015). Case report Mondor’s disease in a patient
after a mammotome biopsy. Videosurgery and Other Miniinvasive Techniques 10 (1): 138–140.
https://doi.org/10.5114/wiitm.2015.49095
Ben Hamida K, Ghalleb M, Triki A, Jebir I, Makhlouf R, Touinsi H. (2021). Mondor's disease
of the breast: a case series. Journal of Medical Case Reports; 15(1):188. doi: 10.1186/s13256-021-
-6.
Lessiani, G., Boccatonda, A., D'Ardes, D., Cocco, G., Di Marco, G., & Schiavone, C. (2020).
Mondor's Disease in SARS-CoV-2 Infection: A Case of Superficial Vein Thrombosis in the Era of
COVID-19. European journal of case reports in internal medicine, 7(10), 001803. https://doi.org/
12890/2020_001803
Eren, M.T., Özveri, H. & Kurtoğlu, H. (2021) Penile Mondor’s in a Covid-19 patient on
prophylactic anti-thrombosis with rivaroxaban: a case report. African Journal of Urology 27, 97.
https://doi.org/10.1186/ s12301-021-00200-7
Mucha, S. R., Dugar, S., McCrae, K., Joseph, D., Bartholomew, J., Sacha, G. L., & Militello, M.
(2020). Coagulopathy in COVID-19: Manifestations and management. Cleveland Clinic journal of
medicine, 87(8), 461–468. https://doi.org/10.3949/ccjm.87a.ccc024
Xie, Y., Xu, E., Bowe, B. et al. (2022), Long-term cardiovascular outcomes of COVID-19.
Nature Medicine 28, 583–590 https://doi.org/10.1038/ s41591-022-01689-3
Agus G. (2020). COVID-19 Era: Mondor’s disease and Rembrandt. What ties?. Veins and
Lymphatics. 9. 10.4081/vl.2020.9107.
Mayor, M., Burón, I., de Mora, J. C., Lázaro, T. E., Hernández-Cano, N., Rubio, F. A., &
Casado, M. (2000). Mondor's disease. International journal of dermatology, 39(12), 922–925.
https://doi.org/10.1046/j.1365-4362.2000.00018.x
Neill, B. C., Rickstrew, J. J., & Liu, D. (2022). Mondor's Disease. Journal of cutaneous and
aesthetic surgery, 15(4), 424–425. https://doi.org/10.4103/JCAS.JCAS_246_20
Amano, M., & Shimizu, T. (2018). Mondor's Disease: A Review of the Literature. Internal
medicine (Tokyo, Japan), 57(18), 2607–2612. https://doi.org/10.2169/internalmedicine.0495-17
Nordlie H.,Tangerud Å. Thorsnes S., Breivik S., (2018) Mondor’s disease,
https://tidsskriftet.no/en/2018/05/medisinen-i-bilder/mondors-disease, retrieved 15.07.2023
Pipal, D. K., Pipal, V. R. (2022). Mondor's Disease: A Rare Cause of Chest Pain. Cureus,
(2), e22320. https://doi.org/10.7759/cureus.22320
Pugh, C. M., & DeWitty, R. L. (1996). Mondor's disease. Journal of the National Medical
Association, 88(6), 359–363.
Balawender, K., Pliszka, A., Surowiec, A., & Rajda, S. (2022). COVID-19 infection as a new
risk factor for penile Mondor disease. BMC urology, 22(1), 57. https://doi.org/10.1186/s12894-022-
-x
Renshaw, L., Dixon, J. M., Anderson, J., & Turnbull, A. K. (2022). Mondor's disease of the
breast: A cutaneous thromboembolic manifestation of Covid-19?. Breast (Edinburgh, Scotland), 66,
–309. https://doi.org/10.1016/j.breast.2022.11.006
Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis
epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory
syndrome coronavirus 2 infection.cJ Vasc Surg Venous Lymphat Disord.c2021;9(1):23–35. Doi:
1016/j.jvsv.2020.08.030
Yamaguchi T. (2022) Mondor disease of the breast, Cleveland Clinic Journal of Medicine, 89
(7) 371-372; DOI: 10.3949/ccjm.89a.21097
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Joanna Wiśniewska-Skomra, Kinga Tylutka, Anna Hapon
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 359
Number of citations: 0